Edwards Lifesciences Sells TMR Heart Laser Distribution Rights to Novadaq Technologies
2007年3月21日 - 10:30PM
PRニュース・ワイアー (英語)
IRVINE, Calif., March 21 /PRNewswire-FirstCall/ -- Edwards
Lifesciences Corporation (NYSE:EW), the world leader in the science
of heart valves, announced today that it has sold the exclusive
U.S. distribution rights and the inventory associated with Edwards'
transmyocardial revascularization (TMR) laser product line to
Novadaq Technologies Inc. (TSX: NDQ). The TMR system is
manufactured by PLC Medical Systems (AMEX:PLC). The sale of the TMR
distribution rights supports Edwards' strategy to focus on
proprietary, physician-preference products. "Edwards remains
committed to expanding our line of innovative specialty products
for our cardiac surgeon partners," said Michael A. Mussallem,
Edwards' chairman and CEO. "We are sharpening our focus on unique
and less invasive technologies that advance the field of cardiac
surgery." Total consideration for this sale is estimated to be
between $8-9 million, which includes the purchase of inventory
valued at approximately $1.4 million and an earn-out based on 2007
sales. This transaction will result in a slight gain in the first
quarter and Edwards will record income from the earn-out during the
remainder of 2007. The company does not expect this transaction to
have a material impact on its 2007 earnings guidance. Sales of this
product were approximately $12 million in 2006. As a result of this
transaction, the Cardiac Surgery Systems product line, which
includes Edwards Research Medical cannula and EMBOL-X technologies,
is now expected to contribute revenues of $55-60 million in 2007.
About Novadaq Technologies Novadaq Technologies Inc. (TSX: NDQ)
develops and commercializes medical imaging systems and real-time
image guided therapies for use in the operating room. Novadaq's
proprietary imaging platform can be used to visualize blood
vessels, nerves and the lymphatic system during surgical
procedures. About Edwards Lifesciences Edwards Lifesciences, a
leader in advanced cardiovascular disease treatments, is the
number-one heart valve company in the world and the global leader
in acute hemodynamic monitoring. Headquartered in Irvine, Calif.,
Edwards focuses on specific cardiovascular opportunities including
heart valve disease, peripheral vascular disease and critical care
technologies. The company's global brands, which are sold in nearly
100 countries, include Carpentier-Edwards, Cosgrove-Edwards,
FloTrac, Fogarty, LifeStent, PERIMOUNT Magna, and Swan-Ganz.
Additional company information can be found at
http://www.edwards.com/. This news release includes forward-looking
statements within the meaning of Section 27A of the Securities Act
of 1933 and Section 21E of the Securities Exchange Act of 1934.
Forward-looking statements are based on estimates and assumptions
made by management of the company and are believed to be
reasonable, though they are inherently uncertain and difficult to
predict. Forward-looking statements involve risks and uncertainties
that could cause actual results or experience to differ materially
from that expressed or implied by the forward-looking statements.
Factors that could cause actual results or experience to differ
materially from that expressed or implied by the forward-looking
statements are detailed in the company's filings with the
Securities and Exchange Commission including its Annual Report on
Form 10-K for the year ended December 31, 2006. Edwards and FloTrac
are trademarks of Edwards Lifesciences Corporation. Edwards
Lifesciences, Carpentier-Edwards, Cosgrove-Edwards, EMBOL-X,
Fogarty, PERIMOUNT Magna and Swan-Ganz are trademarks of Edwards
Lifesciences Corporation and are registered in the United States
Patent and Trademark Office. Lifestent is a trademark of Edwards
Lifesciences AG and is registered in the United States Patent and
Trademark Office. DATASOURCE: Edwards Lifesciences Corporation
CONTACT: Media, Nolan D. Taira, +1-949-250-5070, or Investors,
David K. Erickson, +1-949-250-6826, both of Edwards Lifesciences
Corporation Web site: http://www.edwards.com/
Copyright
P L C Systems (AMEX:PLC)
過去 株価チャート
から 11 2024 まで 12 2024
P L C Systems (AMEX:PLC)
過去 株価チャート
から 12 2023 まで 12 2024
Real-Time news about Plc Systems, (アメリカ証券取引所): 0 recent articles
その他のP L C Systemsニュース記事